Stem Cell Therapeutics Corp., based in Toronto, is Canada's only public company focused on advancing cancer stem cell discoveries into innovative therapies. With strong ties to leading academic institutes and oncology treatment centers in Toronto, the company builds on decades of Canadian stem cell research. Their drug-based therapies aim to stimulate a patient's own resident stem cells to repair neurological function lost due to conditions like stroke, traumatic brain injury, multiple sclerosis, and other neurodegenerative diseases. By leveraging these therapies, Stem Cell Therapeutics aims to provide a cure for nervous system disorders.